Independent US producers are inking PDVSA deals tonight. The upgrader problem, the rig shortage, and a 93-rig gap explain why…
MRNA Doubled on Data Nobody Has Seen Yet
INTerpath-001 topline moved the stock 177% in one day. Hazard ratios, p-values, and survival curves were not released.
Two Surging Stocks Built to Compound
CACI and Gartner are surging for different reasons. Both have durable compounding math.
Four Memory Stocks at the Center of AI’s Biggest Bottleneck
HBM is sold out. DRAM is tightening. These four companies are not equally priced for what comes next.
Rambus Just Got Cheaper. The Market Is Reading the Wrong Number.
A 20% post-earnings drop on record revenue is not a verdict on the business. It is a timing misread on…
Amazon’s Book Destruction Is an AI Data Alarm
A Las Vegas warehouse shows how intense the training data race is, and what it means for Amazon’s frontier model…
The $7M Daily Clock Is Now the Trade
Arb desks price a 70% close. The ticking fee, a March trial, and a CNN divestiture gambit decide this.
Trump Threatens Oman and the Last Off-Ramp
Threatening Oman does not reopen Hormuz faster. It weakens the one channel that makes a deal possible.
Meta Faces a Trial Bigger Than the Number
A $1.4 trillion headline distracts. The injunction could break Meta's model.
DIS Is Down 41% in Five Years. Accumulation May Be Starting.
A new CEO, a $9 billion buyback, and a P/E far below its own history. The market is still pricing…